東京大学医学系研究科 国際保健政策学 東京大学 The University of Tokyo

Department of Global Health Policy

Graduate School of Medicine, The University of Tokyo

Global Burden of Disease

世界の疾病負担研究

死や病気の原因やそれらの影響について地球規模で理解することは、
国家、国家間レベルでの政策決定やプログラム評価にとって不可欠である。
この研究の世界のリーダーであるワシントン大学のInstitute for Health Metric Evaluation と協力し、
国家・地球レベルでの病気がもたらす負担について、正確で最新の計測を行い、
また方法論の改善を行っている。

Understanding the extent and causes of death and disease at a global level is essential
for priority setting and program evaluation nationally and internationally.
The key driver of this complex and challenging task is the Institute
for Health Metric Evaluation (IHME) at the University of Washington.
The Department of Global Health Policy collaborates closely
with the IHME to generate accurate, up-to-date burden of disease assessments
at the national and global level, and to improve the sophisticated methodologies underlying this process.

研究員 Researchers:Kenji Shibuya, Nayu Ikeda 渋谷健司池田奈由
研究トピック Research Topics: Health Outcomes Research 

Recent Publications

GBD 2019 Demographics Collaborators (including Nomura S and Shibuya K). Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396(10258): 1160-203.

Read the Article →

GBD 2019 Diseases and Injuries Collaborators (including Nomura S and Shibuya K). Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396(10258): 1204-22.

Read the Article →

GBD 2019 Risk Factors Collaborators (including Nomura S and Shibuya K). Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396(10258): 1223-49.

Read the Article →

GBD 2019 Viewpoint Collaborators (including Nomura S and Shibuya K). Five insights from the Global Burden of Disease Study 2019. Lancet 2020; 396(10258): 1135-59.

Read the Article →

GBD 2019 Universal Health Coverage Collaborators (including Shuhei Nomura and Kenji Shibuya). Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Aug 27:S0140-6736(20)30750-9.

Read the Article →

Inoue Y, Nomura S, Nishiura C, Hori A, Yamamoto K, Nakagawa T, Honda T, Yamamoto S, Eguchi M, Kochi T, Miyamoto T, Okazaki H, Imai T, Nishihara A, Ogasawara T, Sasaki N, Uehara A, Yamamoto M, Shimizu M, Konishi M, Kabe I, Mizoue T, Dohi S. Loss of working life years due to mortality, sickness absence, or ill-health retirement: A comprehensive approach to estimating disease burden in the workplace. J Epidemiol. 2020 Jul 25.

Read the Article →

Mikkelsen L, Iburg, KM, Adair T, Fürst T, Hegnauer M, von der Lippe E, Moran L, Nomura S, Sakamoto H, Shibuya K, Wengler A, Willbond S, Wood P, Lopez AD. Assessing the quality of cause of death data in six high-income countries: Australia, Canada, Denmark, Germany, Japan and Switzerland. Int J Public Health. 2020 Jan; 65, 17–28.

Read the Article →

Yang JJ, Yu D, Wen W, Saito E, Rahman MS, Shu XO et al. Association of diabetes with all-cause and cause-specific mortality in Asia: a pooled analysis of more than 1 million participants. JAMA Netw Open. 2019;2(4):e192696.

Read the Article →

GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017; 390: 1345-1422.

Read the Article →

GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017; 390: 1260–1344.

Read the Article →

GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017; 390: 1151–1210.

Read the Article →

GBD 2016 Mortality Collaborators. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017; 390: 1084–1150.

Read the Article →

GBD 2016 SDG Collaborators. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. The Lancet. 2017; 390: 1423–59.

Read the Article →

Nomura S, Sakamoto H, Glenn S, Tsugawa Y, Abe SK, Rahman MM, Brown JC, Ezoe S, Fitzmaurice C, Inokuchi T, Kassebaum NJ, Kawakami N, Kita Y, Kondo N, Lim SS, Maruyama S, Miyata H, Mooney MD, Naghavi M, Onoda T, Erika O, Otake Y, Roth GA, Saito E, Tabuchi T, Takasaki Y, Taimura T, Uechi M, Vos T, Wang H, Inoue M, Murray CJL, Shibuya K. Population health and regional variations of disease burden in Japan, 1990–2015: a systematic subnational analysis for the Global Burden of Disease Study 2015. The Lancet. 2017; 390(10101): 1521-1538.

Read the Article →

Kita Sugai M, Gilmour S, Ota E, Shibuya K. Trends in perinatal mortality and its risk factors in Japan: Analysis of vital registration data, 1979–2010. Scientific Reports. 2017; 46681.

Read the Article →